Supplementary Figure 2 from Novel Phosphoinositide 3-Kinase/mTOR Dual Inhibitor, NVP-BGT226, Displays Potent Growth-Inhibitory Activity against Human Head and Neck Cancer Cells In Vitro and In Vivo

PDF file - 1659KB, Apoptosis and autophagy-associated reaction by BGT226. (A) Apoptotic effect of BGT226. HSC3 cells incubated with either BGT226 or cisplatin for 24 h were analyzed for apoptosis-associated protein expression. Arrows indicated the cleavage-form of protein. (B) Effect of AVOs formation in FaDu cells treated with BGT226. Cells were stained with acridine orange. The extent of staining intensity in tested cells was analyzed and plotted by flow cytometry. The left rows represented cells incubated in DMSO or 3MA. The right row showed cells that were treated with BGT226 120 nM with or without the co-treatment of 3MA. The percentage of detected cells in each quadrant is marked on the panel. (C) Evaluation of cathepsin B/D/L (Cat B/D/L) activity in FaDu cells treated with BGT226. The activity of each factor was assessed by its individual activity kit (BioVisiion, CA). For the preparation, we followed manifacturer's protocol after BGT226 treatment of the cells. The samples were then transferred to 96-well plate, with the result read using fluorometer equipped with a 400-nm excitation filter and 505-nm emission filter. The data was then compared to the control, with the ratio ploted and shown in the bar chart.